Sign in or Register   Sign in or Register
  |  

Mouse Anti-ASXL1 Recombinant Antibody (BR039) (CBMAB-BR039LY)

The product is antibody recognizes ASXL1. The antibody 11I4 immunoassay techniques such as: FC, WB.
See all ASXL1 antibodies

Summary

Host Animal
Mouse
Specificity
Human, Mouse, Rat
Clone
BR039
Antibody Isotype
IgG1
Application
FC, WB

Basic Information

Immunogen
A synthetic peptide corresponding to a sequence of human ASXL1 (KKERTWAEA ARLVLENYSDAPMTPKQILQVIEAE).
Specificity
Human, Mouse, Rat
Antibody Isotype
IgG1
Clonality
Monoclonal
Application Notes
The COA includes recommended starting dilutions, optimal dilutions should be determined by the end user.
ApplicationNote
WB0.1-0.5 µg/ml
FC1-3 µg/1x10^6 cells

Formulations & Storage [For reference only, actual COA shall prevail!]

Format
Lyophilized
Buffer
PBS, 4mg trehalose
Preservative
0.05 mg sodium azide
Storage
Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freezethaw cycles.

Target

Full Name
additional sex combs like 1,transcriptional regulator
Introduction
This gene is similar to the Drosophila additional sex combs gene, which encodes a chromatin-binding protein required for normal determination of segment identity in the developing embryo. The protein is a member of the Polycomb group of proteins, which are necessary for the maintenance of stable repression of homeotic and other loci. The protein is thought to disrupt chromatin in localized areas, enhancing transcription of certain genes while repressing the transcription of other genes. The protein encoded by this gene functions as a ligand-dependent co-activator for retinoic acid receptor in cooperation with nuclear receptor coactivator 1. Mutations in this gene are associated with myelodysplastic syndromes and chronic myelomonocytic leukemia. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2009]
Entrez Gene ID
Human171023
Mouse228790
Rat311553
UniProt ID
HumanQ8IXJ9
MouseP59598
RatA0A0G2JU33
Alternative Names
Putative Polycomb group protein ASXL1; Additional sex combs-like protein 1; ASXL1; KIAA0978
Function
Probable Polycomb group (PcG) protein involved in transcriptional regulation mediated by ligand-bound nuclear hormone receptors, such as retinoic acid receptors (RARs) and peroxisome proliferator-activated receptor gamma (PPARG) (PubMed:16606617).
Acts as coactivator of RARA and RXRA through association with NCOA1 (PubMed:16606617).
Acts as corepressor for PPARG and suppresses its adipocyte differentiation-inducing activity (By similarity).
Non-catalytic component of the PR-DUB complex, a complex that specifically mediates deubiquitination of histone H2A monoubiquitinated at 'Lys-119' (H2AK119ub1) (PubMed:20436459).
Acts as a sensor of N6-methyladenosine methylation on DNA (m6A): recognizes and binds m6A DNA, leading to its ubiquitination and degradation by TRIP12, thereby inactivating the PR-DUB complex and regulating Polycomb silencing (PubMed:30982744).
Biological Process
Animal organ morphogenesis Source: GO_Central
Bone marrow development Source: Ensembl
Cell morphogenesis Source: Ensembl
Glomerular visceral epithelial cell development Source: Ensembl
Heart morphogenesis Source: Ensembl
Hemopoiesis Source: Ensembl
Homeostasis of number of cells Source: Ensembl
Lung saccule development Source: Ensembl
Monoubiquitinated histone H2A deubiquitination Source: UniProtKB
Negative regulation of fat cell differentiation Source: UniProtKB
Negative regulation of lipid storage Source: Ensembl
Negative regulation of peroxisome proliferator activated receptor signaling pathway Source: UniProtKB
Positive regulation of retinoic acid receptor signaling pathway Source: UniProtKB
Positive regulation of transcription by RNA polymerase II Source: UniProtKB
Protein deubiquitination Source: Reactome
Regulation of kidney size Source: Ensembl
Response to retinoic acid Source: UniProtKB
Thymus development Source: Ensembl
Transcription, DNA-templated Source: InterPro
Cellular Location
Nucleus
Involvement in disease
Bohring-Opitz syndrome (BOPS): A syndrome characterized by severe intrauterine growth retardation, poor feeding, profound mental retardation, trigonocephaly, prominent metopic suture, exophthalmos, nevus flammeus of the face, upslanting palpebral fissures, hirsutism, and flexion of the elbows and wrists with deviation of the wrists and metacarpophalangeal joints.
Myelodysplastic syndrome (MDS): A heterogeneous group of closely related clonal hematopoietic disorders. All are characterized by a hypercellular or hypocellular bone marrow with impaired morphology and maturation, dysplasia of the myeloid, megakaryocytic and/or erythroid lineages, and peripheral blood cytopenias resulting from ineffective blood cell production. Included diseases are: refractory anemia (RA), refractory anemia with ringed sideroblasts (RARS), refractory anemia with excess blasts (RAEB), refractory cytopenia with multilineage dysplasia and ringed sideroblasts (RCMD-RS); chronic myelomonocytic leukemia (CMML) is a myelodysplastic/myeloproliferative disease. MDS is considered a premalignant condition in a subgroup of patients that often progresses to acute myeloid leukemia (AML).
PTM
Ubiquitinated by TRIP12, leading to its subsequent degradation following binding N6-methyladenosine methylated DNA (m6A).

Xia, Y. K., Zeng, Y. R., Zhang, M. L., Liu, P., Liu, F., Zhang, H., ... & Ye, D. (2021). Tumor-derived neomorphic mutations in ASXL1 impairs the BAP1-ASXL1-FOXK1/K2 transcription network. Protein & cell, 12(7), 557-577.

Burgess, A. E., Kleffmann, T., & Mace, P. D. (2021). Oncogenic truncations of ASXL1 enhance a motif for BRD4 ET-domain binding. bioRxiv.

Hurtado, R., Guirales, F., & Tirado, C. A. (2021). ASXL1 Gene in AML. Journal of the Association of Genetic Technologists, 47(2).

Yamamoto, K., Goyama, S., Asada, S., Fujino, T., Yonezawa, T., Sato, N., ... & Kitamura, T. (2021). A histone modifier, ASXL1, interacts with NONO and is involved in paraspeckle formation in hematopoietic cells. Cell Reports, 36(8), 109576.

Bai, J., Chen, Z., Chen, C., Zhang, M., Zhang, Y., Song, J., ... & Zhou, Y. (2021). Reducing hyperactivated BAP1 attenuates mutant ASXL1-driven myeloid malignancies in human haematopoietic cells. Cancer Letters, 519, 78-90.

Kolovos, P., Nishimura, K., Sankar, A., Sidoli, S., Cloos, P. A., Helin, K., & Christensen, J. (2020). PR-DUB maintains the expression of critical genes through FOXK1/2-and ASXL1/2/3-dependent recruitment to chromatin and H2AK119ub1 deubiquitination. Genome research, 30(8), 1119-1130.

Asada, S., Fujino, T., Goyama, S., & Kitamura, T. (2019). The role of ASXL1 in hematopoiesis and myeloid malignancies. Cellular and Molecular Life Sciences, 76(13), 2511-2523.

Peng, H., Prokop, J., Karar, J., Park, K., Cao, L., Harbour, J. W., ... & Rauscher, F. J. (2018). Familial and somatic BAP1 mutations inactivate ASXL1/2-mediated allosteric regulation of BAP1 deubiquitinase by targeting multiple independent domains. Cancer research, 78(5), 1200-1213.

Ask a question We look forward to hearing from you.
0 reviews or Q&As

Purchasing FAQs
Technical FAQs

Loading...
Have you used Mouse Anti-ASXL1 Recombinant Antibody (BR039)?
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon $30 eGift Card
Submit a review
Loading...
For research use only. Not intended for any clinical use.

Custom Antibody Labeling

We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).

Online Inquiry

Documents

Contact us

  • Tel: (USA)
  • (UK)
  • Fax:
  • Email:

Submit A Review

Go to
Compare